Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

August 31, 2009

Conditions
Superficial Bladder Cancer
Interventions
DRUG

Chemophase

40 mg mitomycin with 800,000 U rHuPH20 total volume of 40 mL instilled

Trial Locations (5)

32608

Malcolm Randall Veterans Administration, Gainesville

34655

Advanced Research Institute, Inc., New Port Richey

85032

BCG Oncology, PC, Phoenix

91942

Medresearch, La Mesa

92801

Advanced Urology Medical Center, Anaheim

Sponsors
All Listed Sponsors
lead

Halozyme Therapeutics

INDUSTRY

NCT00782587 - Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer | Biotech Hunter | Biotech Hunter